Twin reversed arterial perfusion (TRAP) sequence

In-utero treatment

Diana L Farmer, Katrine M. Løfberg

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Background: Twin reversed arterial perfusion (TRAP) sequence or acardiac twinning is a rare congenital anomaly unique to monozygotic multiple gestations. Existence of TRAP requires two conditions: (1) pump or forward flow failure in the acardiac twin and (2) a set of arterioarterial and venovenous placental anastomoses connecting the acardiac and “pump” twins’ circulatory systems. It is considered the most severe malformation of twinning seen in humans. Other historical though less commonly used terms include chorioangiopagus parasiticus and acardiac monster. Incidence is estimated to be 1:35000 pregnancies or 1% of all monochorionic pregnancies [1, 2], though it may be higher given that some cases of TRAP may go undiagnosed due to early pregnancy loss or reabsorption of the acardiac twin [3]. Pathophysiology: In TRAP, one twin, the acardiac, has a non-functioning (pseudoacardius) or absent (holoacardius) heart. This twin is hemodynamically dependent on the structurally normal donor or “pump” twin. Blood is shunted from the “pump” twin, bypassing the placenta, in a retrograde fashion through anomalous arterioarterial anastomoses and perfuses the acardiac twin [4]. The blood reaching the acardiac twin is poorly oxygenated and nutrient deplete. Once in the acardiac’s circulatory system, blood flows passively through the iliac arteries, first perfusing the lower body and extremities. The further deoxygenated blood then perfuses the caudal structures and subsequently flows via the acardiac’s umbilical vein back to the “pump” twin through direct venovenous anastomoses (see Figure 12.2.1). Thus, blood returning to the “pump” twin is a mix of oxygenated blood from the placenta and deoxygenated blood from the acardiac twin.

Original languageEnglish (US)
Title of host publicationFetal Therapy: Scientific Basis and Critical Appraisal of Clinical Benefits
PublisherCambridge University Press
Pages193-199
Number of pages7
ISBN (Print)9780511997778, 9781107012134
DOIs
StatePublished - Jan 1 2009

Fingerprint

Perfusion
Pregnancy
Cardiovascular System
Placenta
Umbilical Veins
Iliac Artery
Lower Extremity
Food
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Farmer, D. L., & Løfberg, K. M. (2009). Twin reversed arterial perfusion (TRAP) sequence: In-utero treatment. In Fetal Therapy: Scientific Basis and Critical Appraisal of Clinical Benefits (pp. 193-199). Cambridge University Press. https://doi.org/10.1017/CBO9780511997778.023

Twin reversed arterial perfusion (TRAP) sequence : In-utero treatment. / Farmer, Diana L; Løfberg, Katrine M.

Fetal Therapy: Scientific Basis and Critical Appraisal of Clinical Benefits. Cambridge University Press, 2009. p. 193-199.

Research output: Chapter in Book/Report/Conference proceedingChapter

Farmer, DL & Løfberg, KM 2009, Twin reversed arterial perfusion (TRAP) sequence: In-utero treatment. in Fetal Therapy: Scientific Basis and Critical Appraisal of Clinical Benefits. Cambridge University Press, pp. 193-199. https://doi.org/10.1017/CBO9780511997778.023
Farmer DL, Løfberg KM. Twin reversed arterial perfusion (TRAP) sequence: In-utero treatment. In Fetal Therapy: Scientific Basis and Critical Appraisal of Clinical Benefits. Cambridge University Press. 2009. p. 193-199 https://doi.org/10.1017/CBO9780511997778.023
Farmer, Diana L ; Løfberg, Katrine M. / Twin reversed arterial perfusion (TRAP) sequence : In-utero treatment. Fetal Therapy: Scientific Basis and Critical Appraisal of Clinical Benefits. Cambridge University Press, 2009. pp. 193-199
@inbook{7d311a60d70b46fe8439f7c16d24a966,
title = "Twin reversed arterial perfusion (TRAP) sequence: In-utero treatment",
abstract = "Background: Twin reversed arterial perfusion (TRAP) sequence or acardiac twinning is a rare congenital anomaly unique to monozygotic multiple gestations. Existence of TRAP requires two conditions: (1) pump or forward flow failure in the acardiac twin and (2) a set of arterioarterial and venovenous placental anastomoses connecting the acardiac and “pump” twins’ circulatory systems. It is considered the most severe malformation of twinning seen in humans. Other historical though less commonly used terms include chorioangiopagus parasiticus and acardiac monster. Incidence is estimated to be 1:35000 pregnancies or 1{\%} of all monochorionic pregnancies [1, 2], though it may be higher given that some cases of TRAP may go undiagnosed due to early pregnancy loss or reabsorption of the acardiac twin [3]. Pathophysiology: In TRAP, one twin, the acardiac, has a non-functioning (pseudoacardius) or absent (holoacardius) heart. This twin is hemodynamically dependent on the structurally normal donor or “pump” twin. Blood is shunted from the “pump” twin, bypassing the placenta, in a retrograde fashion through anomalous arterioarterial anastomoses and perfuses the acardiac twin [4]. The blood reaching the acardiac twin is poorly oxygenated and nutrient deplete. Once in the acardiac’s circulatory system, blood flows passively through the iliac arteries, first perfusing the lower body and extremities. The further deoxygenated blood then perfuses the caudal structures and subsequently flows via the acardiac’s umbilical vein back to the “pump” twin through direct venovenous anastomoses (see Figure 12.2.1). Thus, blood returning to the “pump” twin is a mix of oxygenated blood from the placenta and deoxygenated blood from the acardiac twin.",
author = "Farmer, {Diana L} and L{\o}fberg, {Katrine M.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1017/CBO9780511997778.023",
language = "English (US)",
isbn = "9780511997778",
pages = "193--199",
booktitle = "Fetal Therapy: Scientific Basis and Critical Appraisal of Clinical Benefits",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Twin reversed arterial perfusion (TRAP) sequence

T2 - In-utero treatment

AU - Farmer, Diana L

AU - Løfberg, Katrine M.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Background: Twin reversed arterial perfusion (TRAP) sequence or acardiac twinning is a rare congenital anomaly unique to monozygotic multiple gestations. Existence of TRAP requires two conditions: (1) pump or forward flow failure in the acardiac twin and (2) a set of arterioarterial and venovenous placental anastomoses connecting the acardiac and “pump” twins’ circulatory systems. It is considered the most severe malformation of twinning seen in humans. Other historical though less commonly used terms include chorioangiopagus parasiticus and acardiac monster. Incidence is estimated to be 1:35000 pregnancies or 1% of all monochorionic pregnancies [1, 2], though it may be higher given that some cases of TRAP may go undiagnosed due to early pregnancy loss or reabsorption of the acardiac twin [3]. Pathophysiology: In TRAP, one twin, the acardiac, has a non-functioning (pseudoacardius) or absent (holoacardius) heart. This twin is hemodynamically dependent on the structurally normal donor or “pump” twin. Blood is shunted from the “pump” twin, bypassing the placenta, in a retrograde fashion through anomalous arterioarterial anastomoses and perfuses the acardiac twin [4]. The blood reaching the acardiac twin is poorly oxygenated and nutrient deplete. Once in the acardiac’s circulatory system, blood flows passively through the iliac arteries, first perfusing the lower body and extremities. The further deoxygenated blood then perfuses the caudal structures and subsequently flows via the acardiac’s umbilical vein back to the “pump” twin through direct venovenous anastomoses (see Figure 12.2.1). Thus, blood returning to the “pump” twin is a mix of oxygenated blood from the placenta and deoxygenated blood from the acardiac twin.

AB - Background: Twin reversed arterial perfusion (TRAP) sequence or acardiac twinning is a rare congenital anomaly unique to monozygotic multiple gestations. Existence of TRAP requires two conditions: (1) pump or forward flow failure in the acardiac twin and (2) a set of arterioarterial and venovenous placental anastomoses connecting the acardiac and “pump” twins’ circulatory systems. It is considered the most severe malformation of twinning seen in humans. Other historical though less commonly used terms include chorioangiopagus parasiticus and acardiac monster. Incidence is estimated to be 1:35000 pregnancies or 1% of all monochorionic pregnancies [1, 2], though it may be higher given that some cases of TRAP may go undiagnosed due to early pregnancy loss or reabsorption of the acardiac twin [3]. Pathophysiology: In TRAP, one twin, the acardiac, has a non-functioning (pseudoacardius) or absent (holoacardius) heart. This twin is hemodynamically dependent on the structurally normal donor or “pump” twin. Blood is shunted from the “pump” twin, bypassing the placenta, in a retrograde fashion through anomalous arterioarterial anastomoses and perfuses the acardiac twin [4]. The blood reaching the acardiac twin is poorly oxygenated and nutrient deplete. Once in the acardiac’s circulatory system, blood flows passively through the iliac arteries, first perfusing the lower body and extremities. The further deoxygenated blood then perfuses the caudal structures and subsequently flows via the acardiac’s umbilical vein back to the “pump” twin through direct venovenous anastomoses (see Figure 12.2.1). Thus, blood returning to the “pump” twin is a mix of oxygenated blood from the placenta and deoxygenated blood from the acardiac twin.

UR - http://www.scopus.com/inward/record.url?scp=84924196430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924196430&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511997778.023

DO - 10.1017/CBO9780511997778.023

M3 - Chapter

SN - 9780511997778

SN - 9781107012134

SP - 193

EP - 199

BT - Fetal Therapy: Scientific Basis and Critical Appraisal of Clinical Benefits

PB - Cambridge University Press

ER -